NorthWest Biotherapeutics Inc (NWBO)

[beachlifeisfun]

So I am left wondering what factors are contributing to the longer PFS of the placebo patients in NWBO's trial and what impact this will have with regard to the comparison of PFS in the treatment vs. control groups?--ready4bluesky

I am confused...LL said that everyone in the trial is living longer...she didn't say anything about PFS for the P3. But I think that you are aware of this. I have mentioned this to you and others in the past...I expect that both placebo and experimental patients will have a longer OS due to the crossover option. This is further evidenced by the results of the information arm. I believe that this is the trend that LL is alluding to. Stop try to twist this very positive information. You almost sound like another individual that used to post here and twist a facts into fiction...